Bank of America’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.04M Buy
209,922
+171,612
+448% +$5.56M ﹤0.01% 3126
2025
Q4
$1.01M Sell
38,310
-96,009
-71% -$1.76M ﹤0.01% 4520
2025
Q3
$1.88M Sell
134,319
-238,648
-64% -$2.72M ﹤0.01% 4870
2025
Q2
$3.57M Buy
372,967
+289,446
+347% +$2.75M ﹤0.01% 4224
2025
Q1
$777K Buy
83,521
+17,364
+26% +$225K ﹤0.01% 5399
2024
Q4
$920K Buy
66,157
+11,804
+22% +$214K ﹤0.01% 5096
2024
Q3
$1.28M Buy
54,353
+4,836
+10% +$102K ﹤0.01% 4895
2024
Q2
$792K Buy
49,517
+16,485
+50% +$284K ﹤0.01% 5047
2024
Q1
$542K Buy
33,032
+10,914
+49% +$179K ﹤0.01% 5301
2023
Q4
$306K Sell
22,118
-46
-0.2% -$596 ﹤0.01% 5824
2023
Q3
$305K Buy
22,164
+1,752
+9% +$26K ﹤0.01% 5651
2023
Q2
$348K Buy
20,412
+2,401
+13% +$34.8K ﹤0.01% 5500
2023
Q1
$289K Sell
18,011
-2,951
-14% -$35.1K ﹤0.01% 5724
2022
Q4
$159K Buy
20,962
+7,171
+52% +$50.7K ﹤0.01% 6034
2022
Q3
$121K Sell
13,791
-5,928
-30% -$54.2K ﹤0.01% 6250
2022
Q2
$141K Sell
19,719
-44,407
-69% -$354K ﹤0.01% 6306
2022
Q1
$686K Buy
64,126
+58,401
+1,020% +$693K ﹤0.01% 5572
2021
Q4
$80K Buy
5,725
+4,840
+547% +$96.2K ﹤0.01% 6992
2021
Q3
$15K Buy
+885
New +$16.9K ﹤0.01% 7478

Other funds holding TYRA

Bank of America's TYRA Position: Q1 2026 in Review

Bank of America increased its Tyra Biosciences (TYRA) stake by 448% in Q1 2026, buying an estimated $5.56M and bringing the position to 209,922 shares worth $8.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3126.

Bank of America first reported a position in TYRA in Q3 2021 and has held it in 19 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Bank of America held 209,922 shares of Tyra Biosciences worth $8.04M as of Q1 2026.
  • Bank of America bought 171,612 Tyra Biosciences shares in Q1 2026, an estimated $5.56M.
  • Tyra Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3126 holding.
  • Bank of America first reported a position in Tyra Biosciences in Q3 2021 and has held it in 19 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.